NIAMS, NIH
Bethesda, MD, United States
Hanna Kim completed her B.S. in Biology from Caltech, Pasadena, CA. She obtained an M.D. from the University of California, Irvine. She completed pediatrics residency at Children’s National Medical Center in Washington, DC and pediatric rheumatology fellowship at A.I. Dupont Children’s in Wilmington, DE, Children’s National, and NIAMS/NIH in Bethesda, MD. Currently as a board-certified pediatric rheumatologist and assistant clinical investigator, she is the head of the Juvenile Myositis Pathogenesis and Therapeutics Unit at NIAMS / NIH. She is a member of the Early Career Investigators Subcommittee of ACR.
She does clinical and translational research focused on novel biomarkers and their association with disease activity and pathogenesis, as well as novel treatments in clinical trials in juvenile myositis.
Eli Lilly and Co. (Individual(s) Involved: Self; Ongoing): Eli Lilly and Co. - drug and research support, Other Financial or Material Support
Thursday, November 10, 2022
6:00 PM – 6:45 PM Eastern Time
Friday, November 11, 2022
6:00 PM – 6:45 PM Eastern Time
Saturday, November 12, 2022
6:00 PM – 6:45 PM Eastern Time
Sunday, November 13, 2022
9:00 AM – 9:45 AM Eastern Time
Sunday, November 13, 2022
12:20 PM – 12:35 PM Eastern Time
Sunday, November 13, 2022
1:00 PM – 3:00 PM Eastern Time
Monday, November 14, 2022
5:00 PM – 6:00 PM Eastern Time
